Jazz Pharmaceuticals (JAZZ) PT Raised to $220 at Cowen; 'Transitioning Growth Asset'
Tweet Send to a Friend
Cowen raised its price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $220.00 (from $190.00) while maintaining an Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
